National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$124.25
add to cart

Rights & Permissions

topleft topright

The Healthcare Imperative: Lowering Costs and Improving Outcomes: Workshop Series Summary (2010)
Roundtable on Value & Science-Driven Health Care (VSRT)

Citation Manager

Young, Pierre L., Olsen, LeighAnne. "Synopsis and Overview." The Healthcare Imperative: Lowering Costs and Improving Outcomes: Workshop Series Summary. Washington, DC: The National Academies Press, 2010.

Please select a format:

BibTeX EndNote RefMan


Page
52
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


The Healthcare Imperative: Lowering Costs and Improving Outcomes - Workshop Series Summary

BOX S-2

Excess Cost Domain Estimates: Lower bound totals from workshop discussions*

UNNECESSARY SERVICES

Total excess = $210 B*

  • Overuse: services beyond evidence-established levels

  • Discretionary use beyond benchmarks

    • Defensive medicine

  • Unnecessary choice of higher cost services

INEFFICIENTLY DELIVERED SERVICES

Total excess = $130 B*

  • Mistakes—medical errors, preventable complications

  • Care fragmentation

  • Unnecessary use of higher cost providers

  • Operational inefficiencies at care delivery sites

    • Physician offices

    • Hospitals

EXCESS ADMINISTRATIVE COSTS

Total excess = $190 B*

  • Insurance-related administrative costs beyond benchmarks

    • Insurers

    • Physician offices

    • Hospitals

    • Other providers

  • Insurer administrative inefficiencies

  • Care documentation requirement inefficiencies

PRICES THAT ARE TOO HIGH

Total excess = $105 B*

  • Service prices beyond competitive benchmarks

    • Physician services

      1. Specialists

      2. Generalists

    • Hospital services

  • Product prices beyond competitive benchmarks

    • Pharmaceuticals

    • Medical devices

    • Durable medical equipment

MISSED PREVENTION OPPORTUNITIES

Total excess = $55 B*

  • Primary prevention

  • Secondary prevention

  • Tertiary prevention

FRAUD

Total excess = $75 B*

  • All sources—payer, clinician, patient

  

*Lower bound totals of various estimates, adjusted to 2009 total expenditure level.

Page
52